These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 33820507)

  • 41. Coumarin derivatives: an updated patent review (2015-2016).
    Detsi A; Kontogiorgis C; Hadjipavlou-Litina D
    Expert Opin Ther Pat; 2017 Nov; 27(11):1201-1226. PubMed ID: 28756713
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Current developments of coumarin compounds in medicinal chemistry.
    Peng XM; Damu GL; Zhou C
    Curr Pharm Des; 2013; 19(21):3884-930. PubMed ID: 23438968
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anti-breast Cancer Potential of Natural and Synthetic Coumarin Derivatives.
    Song F; Huo X; Guo Z
    Curr Top Med Chem; 2021; 21(18):1692-1709. PubMed ID: 33655862
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Coumarin: a promising scaffold for anticancer agents.
    Kaur M; Kohli S; Sandhu S; Bansal Y; Bansal G
    Anticancer Agents Med Chem; 2015; 15(8):1032-48. PubMed ID: 25553437
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Coumarin derivatives: an updated patent review (2012-2014).
    Katsori AM; Hadjipavlou-Litina D
    Expert Opin Ther Pat; 2014 Dec; 24(12):1323-47. PubMed ID: 25327901
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Design and Synthesis of Novel Coumarin Conjugated Acetamides as Promising Anticancer Agents: An In Silico and In Vitro Approach.
    Mamatha SV; Belagali SL; Bhat M; Kumbar VM
    Anticancer Agents Med Chem; 2021; 21(11):1431-1440. PubMed ID: 32664844
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anticancer mechanism of coumarin-based derivatives.
    Yadav AK; Maharjan Shrestha R; Yadav PN
    Eur J Med Chem; 2024 Mar; 267():116179. PubMed ID: 38340509
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comprehensive Review on Medicinal Applications of Coumarin-Derived Imine-Metal Complexes.
    Patil SA; Kandathil V; Sobha A; Somappa SB; Feldman MR; Bugarin A; Patil SA
    Molecules; 2022 Aug; 27(16):. PubMed ID: 36014460
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of antifungal activities and structure-activity relationships of coumarin derivatives.
    Song PP; Zhao J; Liu ZL; Duan YB; Hou YP; Zhao CQ; Wu M; Wei M; Wang NH; Lv Y; Han ZJ
    Pest Manag Sci; 2017 Jan; 73(1):94-101. PubMed ID: 27570117
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesis of new conjugated coumarin-benzimidazole hybrids and their anticancer activity.
    Paul K; Bindal S; Luxami V
    Bioorg Med Chem Lett; 2013 Jun; 23(12):3667-72. PubMed ID: 23642480
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transition metal-catalyzed synthesis of new 3-substituted coumarin derivatives as antibacterial and cytostatic agents.
    Sokol I; Toma M; Krnić M; Macan AM; Drenjančević D; Liekens S; Raić-Malić S; Gazivoda Kraljević T
    Future Med Chem; 2021 Nov; 13(21):1865-1884. PubMed ID: 34533068
    [No Abstract]   [Full Text] [Related]  

  • 52. Application of a Validated QSTR Model for Repurposing COX-2 Inhibitor Coumarin Derivatives as Potential Antitumor Agents.
    Tugcu G; Sipahi H; Aydin A
    Curr Top Med Chem; 2019; 19(13):1121-1128. PubMed ID: 31210111
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Therapeutic Effects of Coumarins with Different Substitution Patterns.
    Flores-Morales V; Villasana-Ruíz AP; Garza-Veloz I; González-Delgado S; Martinez-Fierro ML
    Molecules; 2023 Mar; 28(5):. PubMed ID: 36903660
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Design, Synthesis, and Biological Evaluation of Coumarin-Triazole Hybrid Molecules as Potential Antitumor and Pancreatic Lipase Agents.
    Kahveci B; Yılmaz F; Menteşe E; Ülker S
    Arch Pharm (Weinheim); 2017 Aug; 350(8):. PubMed ID: 28543820
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gold(I)-Coumarin-Caffeine-Based Complexes as New Potential Anti-Inflammatory and Anticancer Trackable Agents.
    Trommenschlager A; Chotard F; Bertrand B; Amor S; Richard P; Bettaïeb A; Paul C; Connat JL; Le Gendre P; Bodio E
    ChemMedChem; 2018 Nov; 13(22):2408-2414. PubMed ID: 30203922
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An insight into the therapeutic applications of coumarin compounds and their mechanisms of action.
    Garg SS; Gupta J; Sharma S; Sahu D
    Eur J Pharm Sci; 2020 Sep; 152():105424. PubMed ID: 32534193
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recent advances in coumarins and 1-azacoumarins as versatile biodynamic agents.
    Kulkarni MV; Kulkarni GM; Lin CH; Sun CM
    Curr Med Chem; 2006; 13(23):2795-818. PubMed ID: 17073630
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Strong in vitro and vivo cytotoxicity of novel organoplatinum(II) complexes with quinoline-coumarin derivatives.
    Qin QP; Wang ZF; Huang XL; Tan MX; Zou BQ; Liang H
    Eur J Med Chem; 2019 Dec; 184():111751. PubMed ID: 31593828
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Microwave assisted synthesis of dihydrobenzo[4,5]imidazo[1,2-a]pyrimidin-4-ones; synthesis, in vitro antimicrobial and anticancer activities of novel coumarin substituted dihydrobenzo[4,5]imidazo[1,2-a]pyrimidin-4-ones.
    Puttaraju KB; Shivashankar K; Chandra ; Mahendra M; Rasal VP; Venkata Vivek PN; Rai K; Chanu MB
    Eur J Med Chem; 2013 Nov; 69():316-22. PubMed ID: 24056147
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Design, synthesis, cytotoxicity and mechanism of novel dihydroartemisinin-coumarin hybrids as potential anti-cancer agents.
    Yu H; Hou Z; Tian Y; Mou Y; Guo C
    Eur J Med Chem; 2018 May; 151():434-449. PubMed ID: 29649740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.